Drugs for Renal Tubular Acidosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 20)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Potassium citrate |
Approved, Investigational, Vet_approved |
Phase 3 |
|
866-84-2 |
|
Synonyms:
Potassium citrate anhydrous
Potassium citric acid
|
Tripotassium 2-hydroxypropane-1,2,3-tricarboxylate
Tripotassium citrate
|
|
2 |
|
Sodium citrate |
Approved, Investigational |
Phase 3 |
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
3 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
4 |
|
Expectorants |
|
Phase 3 |
|
|
|
5 |
|
Respiratory System Agents |
|
Phase 3 |
|
|
|
6 |
|
Citrate |
|
Phase 3 |
|
|
|
7 |
|
diuretics |
|
Phase 3 |
|
|
|
8 |
|
Rifampicin |
Approved |
Phase 2 |
|
13292-46-1 |
135512673 5381226 135900090 |
Synonyms:
2,15,17,23,27,29-Hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{[(4-methylpiperazin-1-yl)imino]methyl}-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1,.0,]triaconta-1(28),2,4,9,19,21,23,25(29),26-nonaen-13-yl acetic acid
3-(((4-METHYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN SV
Archidyn
BA-411661E
BA-41166E
Benemycin
EREMFAT
L-5103
L-5103 Lepetit
L-5103-LEPETIT
NIH-10782
NSC-113926
R/AMP
RAMP
Rfamipicin
RFP
Rifa
Rifadin
Rifadin IV
Rifadin®|rifampin
Rifadine
Rifagen
|
Rifaldazin
Rifaldazine
Rifaldin
RIFAMPICIN
Rifampicin SV
Rifampicina
Rifampicine
Rifampicinum
Rifampin
Rifamycin
RIFAMYCIN AMP
Rifaprodin
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactin
Rimazid
Rofact
Tubocin
|
|
9 |
|
Calcium, Dietary |
|
Phase 2 |
|
|
|
10 |
|
Anti-Bacterial Agents |
|
Phase 2 |
|
|
|
11 |
|
Anti-Infective Agents |
|
Phase 2 |
|
|
|
12 |
|
Antitubercular Agents |
|
Phase 2 |
|
|
|
13 |
|
Antibiotics, Antitubercular |
|
Phase 2 |
|
|
|
14 |
|
Calcium |
Nutraceutical |
Phase 2 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
15 |
|
Carbamide peroxide |
Approved |
|
|
124-43-6 |
|
Synonyms:
Carbamide peroxide
Hydrogen peroxide carbamide
Urea dioxide
|
Urea hydrogen peroxide
Urea peroxide
|
|
16 |
|
Topiramate |
Approved |
|
|
97240-79-4 |
5284627 |
Synonyms:
[(1R,2S,6S,9R)-4,4,11,11-TETRAMETHYL-3,5,7,10,12-PENTAOXATRICYCLO[7.3.0.0^{2,6}]DODECAN-6-YL]METHYL SULFAMATE
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamic acid
2,3-4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
|
Epitomax
epitomax|Eprontia® (liquid formulation)|MCN-4853|RWJ-17021|Topamax®
MCN-4853
QUDEXY XR
RWJ-17021
RWJ-17021-000
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Tipiramic acid
Topamax
Topamax sprinkle
TOPIRAMATE
topiramate tablet
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
TPM
Trokendi XR
USL255
USL-255
|
|
17 |
|
Fludrocortisone |
Approved, Investigational |
|
|
127-31-1 |
31378 |
Synonyms:
(8S,9R,10S,11S,13S,14S,17R)-9-FLUORANYL-10,13-DIMETHYL-11,17-BIS(OXIDANYL)-17-(2-OXIDANYLETHANOYL)-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9R,10S,11S,13S,14S,17R)-9-FLUORO-11,17-DIHYDROXY-17-(2-HYDROXY-1-OXOETHYL)-10,13-DIMETHYL-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9R,10S,11S,13S,14S,17R)-9-FLUORO-11,17-DIHYDROXY-17-(2-HYDROXYACETYL)-10,13-DIMETHYL-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9R,10S,11S,13S,14S,17R)-9-FLUORO-17-GLYCOLOYL-11,17-DIHYDROXY-10,13-DIMETHYL-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
9 alpha Fludrohydrocortisone
9 alpha Fluoro 17 hydroxycorticosterone
9 alpha Fluorohydrocortisone
9 alpha-Fluoro-17-hydroxycorticosterone
9 alpha-Fluorohydrocortisone
9 Fluoro 17 hydroxycortisone
9 Fluorocortisol
9 Fluorohydrocortisone
9α-Flourocortisol|Florinef®
9a-FLUOROCORTISOL
9ALPHA-FLUOROCORTISOL
9-Fluoro-17-hydroxycortisone
9-Fluorocortisol
|
9-Fluorohydrocortisone
9Α-FLOUROCORTISOL
9Α-fluorocortisol
Astonin
Astonin H
Astonin merck
Astonin-H
FCOL
FLORINEF
FLUDROCORTISON
Fludrocortisona
FLUDROCORTISONE
Fludrocortisonum
FLUOHYDROCORTISONE
Merck brand OF fludrocortisone
Merck, astonin
|
|
18 |
|
Furosemide |
Approved, Vet_approved |
|
|
54-31-9 |
3440 |
Synonyms:
2-Furfurylamino-4-chloro-5-sulfamoylbenzoate
2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid
2-Furfurylamino-4-chloro-5-sulphamoylbenzoate
2-Furfurylamino-4-chloro-5-sulphamoylbenzoic acid
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulfamoylanthranilate
4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulphamoylanthranilate
4-Chloro-N-furfuryl-5-sulphamoylanthranilic acid
Acetic acid potassium salt
Aisemide
Aldalix
Aldic
Aluzine
ALUZINE 20
ALUZINE 40
ALUZINE 500
Anfuramaide
Apo-frusemide
Apo-furosemide
AQUAMED
Aquarid
Aquasin
Arasemide
Beronald
Bioretic
Bristab
Bristurin
Cetasix
Depix
Desal
Desdemin
Di-Ademil
DIHYDROFLUMETHIAZIDE
dihydroflumethiazide|frusemide|Lasix®|methforylthiazidine
Dirine
Disal
Discoid
Disemide
Diucardin
Diumide-K
Diural
Diurapid
DIURESAL
Diuretic salt
Diurin
Diurolasa
Diusemide
Diusil
Diuzol
Dranex
Dryptal
Durafurid
Edemid
Edenol
Eliur
Elodrine
Endural
Errolon
Eutensin
Farsix
Finuret
Fluidrol
Fluss
Franyl
FROOP
FRUMAX
Frumex
Frumide
Frumil
Frusedan
Frusema
Frusemid
Frusemide
Frusemin
Frusenex
Frusetic
Frusid
FRUSOL
Fulsix
Fuluvamide
Fuluvamine
Furanthril
Furanthryl
Furantral
Furantril
Furanturil
Furesis
Furetic
Furex
Furfan
Furix
Furmid
Furo-basan
Furobeta
Furocot
Furodiurol
Furodrix
Furomen
Furomex
Furomide m.d.
Furo-puren
Furorese
Furosan
Furose
Furosedon
Furosemid
Furosemida
Furosemida [INN-Spanish]
Furosemide
|
Furosemide "mita"
Furosemide monohydrochloride
Furosemide monosodium salt
Furosemidu
Furosemidu [Polish]
Furosemidum
Furosemidum [INN-Latin]
Furosemix
Furoside
Furosifar
Furosix
Furoter
Furovite
Fursemid
Fursemida
Fursemide
Fursol
Fusid
Fusidic acid
Golan
Hissuflux
Hydol
Hydrenox
Hydrex
Hydro
Hydroled
Hydro-rapid
Impugan
Jenafusid
Katlex
Kofuzon
Kolkin
Kutrix
Lasemid
Lasex
Lasiletten
Lasilix
Lasix
LASIX (TN)
LASIX RET
Lasix retard
Lasix Special
Laxur
Lazix
LB-502
Leodrine
Less diur
Liside
Logirene
Lowpston
Lowpstron
Luscek
Macasirool
Marsemide
Metflorylthiazidine
METHFORYLTHIAZIDINE
Mirfat
Mita
Moilarorin
Myrosemide
Nadis
Nelsix
Neo-renal
Nephron
Nicorol
Novosemide
NSC-269420
Octan draselny
Odemase
Odemex
Oedemex
Olmagran
Osyrol
Polysquall a
Prefemin
Profemin
Promedes
Promide
Protargen
Puresis
Radisemide
Radonna
Radouna
Retep
Rodiuran
Rontyl
Rosemide
Rosis
Rusyde
Sal diureticum
Salinex
Salix
Salix (brand OF furosemide)
Salurex
Salurid
Saluron
Seguril
Selectofur
Sigasalur
Sisuril
Spirofur
Synephron
TENKOFRUSE
Transit
Trofurit
Uremide
Uresix
Urex
Urex-m
Urian
Uridon
Uritol
Urosemide
Vergonil
Vesix
Yidoli
Zafimida
|
|
19 |
|
Sodium Potassium Chloride Symporter Inhibitors |
|
|
|
|
|
20 |
|
Anti-Inflammatory Agents |
|
|
|
|
|
Interventional clinical trials:
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Phase 3B Open-Label Extension Of Study B23CS (ARENA 2) Evaluating The Continued Safety And Efficacy Of ADV7103 In Subjects With Primary Distal Renal Tubular Acidosis |
Unknown status |
NCT03831152 |
Phase 3 |
ADV7103 |
2 |
A Phase 3 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Withdrawal Study Evaluating ADV7103 In Pediatric and Adult Subjects With Distal Renal Tubular Acidosis (dRTA) |
Not yet recruiting |
NCT03644706 |
Phase 3 |
ADV7103;Placebo |
3 |
Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Inactivating Mutations in the CYP24A1 Gene |
Recruiting |
NCT03301038 |
Phase 2 |
Rifampin |
4 |
Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Idiopathic Infantile Hypercalcemia |
Recruiting |
NCT03384121 |
Phase 1 |
Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension |
5 |
Incidence of Renal Tubular Acidosis in Nephrology Unit in Assiut University Childern Hospital (AUCH) |
Unknown status |
NCT03268460 |
|
|
6 |
Renal Tubular Acidosis in Incident Renal Transplant Recipients |
Unknown status |
NCT01283880 |
|
|
7 |
Use of Sodium Bicarbonate to Alkalinize Serum/Urine in Pediatric Patients Treated With Topiramate (Pilot Study) |
Unknown status |
NCT03354507 |
|
|
8 |
Renal Tubular Acidosis is Highly Prevalent in Critically Ill Patients |
Completed |
NCT02392091 |
|
|
9 |
Mircera In Patients With CKD Stages III-IV Not On Dialysis: Observational, Non-interventional Cohort Study |
Completed |
NCT02490514 |
|
|
10 |
Comparison of Furosemide/Fludrocortisone With Ammonium Chloride Loading Test in the Diagnosis of Incomplete dRTA in Kidney Stone Formers |
Completed |
NCT01690039 |
|
Furosemide-Fludrocortisone-Test (test for urinary acidification) |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Citric Acid
CITRIC ACID GRANULES
citric acid monohydrate
Citric Acid, Anhydrous
|
CITRIC ACID,HYDROUS
CITRUS NARINGININE
Sodium Bicarbonate
SODIUM BICARBONATE PWDR
|
|